Swiss National Bank
ORGO icon

Swiss National Bank’s Organogenesis Holdings ORGO Stock Holding History

Swiss National Bank’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-158,700
Closed -$505K – 2592
2023
Q3 		$505K Buy
+158,700
New +$504K ﹤0.01% 2509
2023
Q2 		– Sell
-127,100
Closed -$271K – 2642
2023
Q1 		$271K Sell
127,100
-9,300
-7% -$23K ﹤0.01% 2622
2022
Q4 		$367K Hold
136,400
– – ﹤0.01% 2627
2022
Q3 		$442K Hold
136,400
– – ﹤0.01% 2606
2022
Q2 		$666K Buy
136,400
+60,300
+79% +$371K ﹤0.01% 2540
2022
Q1 		$580K Buy
76,100
+5,600
+8% +$43.3K ﹤0.01% 2565
2021
Q4 		$651K Hold
70,500
– – ﹤0.01% 2603
2021
Q3 		$1M Hold
70,500
– – ﹤0.01% 2437
2021
Q2 		$1.17M Buy
+70,500
New +$1.31M ﹤0.01% 2414

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Swiss National Bank's ORGO Position: Q4 2023 in Review

Swiss National Bank sold out of Organogenesis Holdings (ORGO) in Q4 2023, closing a stake of 158,700 shares — an estimated $505K sold.

Swiss National Bank first reported a position in ORGO in Q2 2021 and held it in 9 quarters. The position peaked at $1.17M in Q2 2021. 108 funds tracked by Wall St. Rank hold ORGO as of Q4 2023.

  • Swiss National Bank reported no remaining Organogenesis Holdings position as of Q4 2023 after selling out during the quarter.
  • Swiss National Bank sold 158,700 Organogenesis Holdings shares in Q4 2023, an estimated $505K.
  • Swiss National Bank first reported a position in Organogenesis Holdings in Q2 2021 and held it in 9 quarters.
  • Swiss National Bank's Organogenesis Holdings position peaked at $1.17M in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2023.

Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.